We are live on ! Find out more
ORI

Oak Ridge Investments Portfolio holdings

AUM $1.77B
1-Year Est. Return 63.16%
This Fund
S&P 500
This Quarter Est. Return
+8.37%
1 Year Est. Return
+63.16%
3 Year Est. Return
+207.98%
5 Year Est. Return
+285.85%
10 Year Est. Return
+1,406.08%
AUM
$2.98B
AUM Growth
-$107M
Cap. Flow
-$289M
Cap. Flow %
-9.71%
Top 10 Hldgs %
23.2%
Holding
159
New
12
Increased
42
Reduced
87
Closed
18

Top Sells

Rank Stock Value
1
TXRH icon
Texas Roadhouse
TXRH
+$44.8M
2
BURL icon
Burlington
BURL
+$43.3M
3
MNRO icon
Monro
MNRO
+$23.2M
4
XLRN
Acceleron Pharma
XLRN
+$23.1M
5
SLAB icon
Silicon Laboratories
SLAB
+$22.9M

Sector Composition

Rank Sector Weight
1 Healthcare 24.17%
2 Industrials 21.37%
3 Technology 18.48%
4 Consumer Discretionary 12.78%
5 Consumer Staples 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
76
PepsiCo
PEP
$189B
$13.1M 0.44%
117,134
+13,461
+13% +$1.44M
INCY icon
77
Incyte
INCY
$24.6B
$11.4M 0.38%
85,211
-3,508
-4% -$447K
ANSS
78
DELISTED
Ansys
ANSS
$10.5M 0.35%
98,324
+17,518
+22% +$1.75M
AME icon
79
Ametek
AME
$58.4B
$10.5M 0.35%
193,975
+35,447
+22% +$1.87M
ALXN
80
DELISTED
Alexion Pharmaceuticals
ALXN
$10.3M 0.34%
84,625
+11,943
+16% +$1.54M
TVTX icon
81
Travere Therapeutics
TVTX
$6.1B
$9.59M 0.32%
519,443
-93,683
-15% -$1.83M
MDLZ icon
82
Mondelez International
MDLZ
$79B
$9.57M 0.32%
222,179
+24,421
+12% +$1.08M
CTSH icon
83
Cognizant
CTSH
$25.2B
$9.42M 0.32%
158,329
+23,026
+17% +$1.32M
SBUX icon
84
Starbucks
SBUX
$120B
$9.33M 0.31%
159,717
+21,973
+16% +$1.24M
CAH icon
85
Cardinal Health
CAH
$55.5B
$9.12M 0.31%
111,832
+11,083
+11% +$872K
AYI icon
86
Acuity Brands
AYI
$10.8B
$8.56M 0.29%
41,973
-2,270
-5% -$480K
BFH icon
87
Bread Financial
BFH
$4.57B
$8.5M 0.29%
42,781
+7,955
+23% +$1.51M
INTC icon
88
Intel
INTC
$500B
$8.48M 0.28%
235,163
+25,335
+12% +$917K
VRSK icon
89
Verisk Analytics
VRSK
$25B
$8.31M 0.28%
102,368
-7,498
-7% -$616K
FTV icon
90
Fortive
FTV
$18.4B
$7.79M 0.26%
205,271
+57,681
+39% +$2.07M
KDNY
91
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$7.74M 0.26%
143,991
-39,036
-21% -$2.21M
TDG icon
92
TransDigm Group
TDG
$70.3B
$7.4M 0.25%
33,633
+6,080
+22% +$1.45M
DKS icon
93
Dick's Sporting Goods
DKS
$17.8B
$7.35M 0.25%
151,095
+5,766
+4% +$292K
VFC icon
94
VF Corp
VFC
$6.03B
$7.09M 0.24%
136,944
+18,104
+15% +$893K
EOG icon
95
EOG Resources
EOG
$72.8B
$6.78M 0.23%
69,514
+8,617
+14% +$859K
CHD icon
96
Church & Dwight Co
CHD
$24.5B
$6.55M 0.22%
131,269
-153,954
-54% -$7.36M
BIIB icon
97
Biogen
BIIB
$30.8B
$6.4M 0.22%
23,418
+3,569
+18% +$1.01M
JBTM
98
JBT Marel
JBTM
$6.63B
$6.2M 0.21%
+70,472
New +$6.11M
XPO icon
99
XPO
XPO
$23.7B
$5.76M 0.19%
348,063
+249,877
+254% +$4.08M
GILD icon
100
Gilead Sciences
GILD
$164B
$5.52M 0.19%
81,225
+14,441
+22% +$1.02M

Similar funds

Oak Ridge Investments's Q1 2017 Portfolio in Review

As of Q1 2017, Oak Ridge Investments held 159 positions worth $2.98B, down 3.5% from $3.09B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oak Ridge Investments withdrew a net $289M in Q1 2017, closing 18 positions and reducing 87 holdings. Its most notable exit was Texas Roadhouse, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

Against the trend, Oak Ridge Investments opened a new position in Snyders-Lance, Inc. worth $33.7M.

  • Oak Ridge Investments's largest Q1 2017 buy was Snyders-Lance, Inc.: 836,156 shares worth $33.7M.
  • Oak Ridge Investments added most to e.l.f. Beauty in Q1 2017, an estimated $30.5M increase.
  • Oak Ridge Investments's biggest Q1 2017 reduction was Burlington, cutting an estimated $43.3M.
  • Oak Ridge Investments fully exited Texas Roadhouse in Q1 2017, selling an estimated $44.8M.
  • Oak Ridge Investments's ten largest holdings make up 23% of its $2.98B portfolio in Q1 2017.
  • Oak Ridge Investments opened 12 new positions and closed 18 in Q1 2017.
  • Oak Ridge Investments's portfolio value fell 3.5% quarter-over-quarter to $2.98B.

Based on Oak Ridge Investments's 13F filing for Q1 2017, filed 15 May 2017.